about
Hepatitis G virus infection in chronic liver diseaseHepatitis G virus infection in fulminant hepatic failureQuantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramersComparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patientsComputational models of liver fibrosis progression for hepatitis C virus chronic infection.Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.Hepatitis C Virus NS3/4A Protease Inhibitors.Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective.Overcoming drug resistance in HSV, CMV, HBV and HCV infection.[Molecular epidemiology studies on the immigrant population in Spain].Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV.Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications.Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patients.Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation.Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients.Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.Resumen de congreso: 20 años después del primer Simposium Internacional sobre el virus de la hepatitis C y otros virus relacionados[Immune cellular response in hepatitis C]Hepatitis C and liver transplantation[Coinfection with the hepatitis C virus and human immunodeficiency virus: clinical and biologic implications]Genomic medicine reaches HCV-related liver transplantation: hopes and clinical and public health implicationsA population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area
P50
Q27477828-690DA5C4-4C34-40F3-8062-775ED7C2BB01Q27480284-37645DB0-BD37-46E9-A739-C758045498E4Q27485114-FA35ECA5-A9FE-46B4-A779-C82659860926Q27485751-81C7B035-7867-408C-94CE-BFCE2F101F97Q33995110-D51D2801-A72E-4BF8-AA49-E12F5942A76AQ35917596-8CDB29BE-FAC0-4D0B-9DCE-3E11A986CF12Q36149881-D8EA7083-D404-4C2B-9914-739E4097B693Q37320632-5485670C-4D74-4EF8-A9F1-CCD96A1C7C45Q38156875-747DD6CD-630D-4EEB-8ECC-4751786AF6A8Q38622013-A18BECE4-CC3F-464F-8CFF-4706977A481AQ41651538-68D03681-D4DF-4811-921B-59F4A01CBDF4Q41710703-676B39E6-2D94-4BAB-9F42-8C3263B07158Q42980987-E70E1200-3D31-4D08-81B3-DF57DF29828BQ42982511-0DE70F4C-18F1-42DB-AA03-3AFF00727984Q42983090-C6701FD5-8A1D-4503-9D4D-E1BFCDF9ACE8Q42983390-364B9E65-C352-4506-987E-91734AADA041Q42984517-7CC45444-B8A4-4106-8652-51E5EACFA1ABQ42986452-66D43E40-7FB2-486D-AAF4-8B12F7950C14Q42992257-18CDB619-BB10-420C-BB78-A33A2FE3C579Q42997812-4CDFBB13-E6E8-4323-86D8-D51DE6960C28Q42999371-8F091D76-EC74-4466-BDC8-6C093DDC29F3Q43049418-BD1E7B42-4FAC-44F2-83B6-592706A3BACCQ47413448-3DA8A60D-12A4-4EF9-99F8-94D072870FFDQ54258514-4B03173E-24C3-49B5-BC73-75A467AB1E19Q55339340-47664D20-4693-4D4B-AE12-8608C92BA20AQ59781837-45B2C759-C3BC-44AF-81B6-58509DBFA2A7Q73696168-99BBF844-B11B-4759-AF0D-8B8C0BC81DC9Q77110599-58993BB5-8EB9-40AD-A3BC-71647AB727F5Q78046517-DB35FE6C-4E29-4A07-880F-6DE0B03D7B74Q83331743-76C9660F-79BB-43BE-AAB5-5DEF51B49C4AQ89655373-189A939D-96F8-4A47-BEB3-6110650638CD
P50
description
researcher
@en
name
F X López-Labrador
@en
F X López-Labrador
@nl
type
label
F X López-Labrador
@en
F X López-Labrador
@nl
prefLabel
F X López-Labrador
@en
F X López-Labrador
@nl
P106
P31
P496
0000-0002-9403-8258